*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>(S)-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-5-yl) is a key chiral intermediate for novel kinase inhibitors. Synthesized via asymmetric catalysis and nucleophilic substitution. Molecular formula: C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>7</sub>O; CAS: <strong>Not Available</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceuticals:</strong> Precursor for developing oncology drugs targeting specific mutation profiles.</li>
<li><strong>CRO/CDMO:</strong> Used in process development for high-purity API manufacturing.</li>
<li><strong>Research:</strong> Essential reagent for mechanistic studies in signal transduction pathways.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent racemization. Requires PPE handling due to potential mutagenicity. Not for direct clinical use; strictly for industrial synthesis only.</p>